Previous 10 | Next 10 |
DURHAM, N.C., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its second quarter 2022 financial results on Thursday, August 11 th . Novan management will host a conference call and l...
Novan ( NASDAQ: NOVN ) stock gained over 11% on Tuesday after Oppenheimer began coverage with Outperform rating, saying it is positioned for commercial success as it prepares NDA filing for topical nitric oxide-releasing drug SB206. Th rating is in-line with bullish...
Novan ( NASDAQ: NOVN ) reached an agreement with Evening Post for payment, satisfaction and termination of its secured promissory note and security agreement related to Mar.11, 2022 acquisition of EPI Health. Novan and EPG agreed that on the latter's receipt of $...
– Novan and Evening Post Group enter into a loan payoff and termination agreement, fully satisfying the promissory note and all related obligations – – Novan saves $11.1 million in principal and future interest payments with this agreement – &...
West Fraser Timber ( WFG ) +26% gets joint takeover offer from CVC, Kronospan - Reuters. Applied Blockchain ( APLD ) +25% secures hosting capacity to support its bitcoin mining operations. Apellis Pharmaceuticals ( APLS ) +25% as FDA grants priority r...
Novan Announces Publication of Positive Results from Pivotal Phase 3 Study of Berdazimer Gel, 10.3% (SB206) in Patients with Molluscum Contagiosum in JAMA Dermatology PR Newswire – The B-SIMPLE4 pivotal Phase 3 clinical study of berdazimer gel, 10.3% (SB206) is ...
DURHAM, N.C., June 13, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced the closing of the Company’s previously announced registered direct offering priced at-the-market under Nasdaq rules with an institutiona...
Novan (NASDAQ:NOVN) shares dropped ~17% pre-market after the company announced a $15M stock and warrant offering priced at-the-market under Nasdaq rules. The medical dermatology company is selling to an investor: (i) 2,080,696 shares of its common stock and accompanying warrants to ...
DURHAM, N.C., June 09, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced it has entered into a definitive agreement with an institutional investor to sell to the investor, in a registered direct offering priced at-the...
Evofem Biosciences (EVFM) -43% on planned public offering. Ross Stores (ROST) -23% on Q1 results. Bright Green (BGXX) -12%. NeuroMetrix (NURO) -10%. Burlington Stores (BURL) -10%. Novan, Inc. (NOVN) -8%. Upstart Holdings (UPST) -7% Saxena White P.A. files new securiti...
News, Short Squeeze, Breakout and More Instantly...
– The Company and Ligand Pharmaceuticals sign agreement to sell substantially all of Novan’s assets under Section 363 of the U.S. Bankruptcy Code, along with a commitment from Ligand to fund $15 million in debtor-in-possession financing – – Progression toward...
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2023 Annual Meeting of Stockholders (“ASM”) being held on Tuesday, June 6...
– Company directing resources on the potential approval of berdazimer gel, 10.3% (SB206) for molluscum contagiosum – – Process to explore a sale or out-license of commercial assets or other business transaction continues – – Continued progress ...